HK20180A - Vinca alkaloid derivatives - Google Patents

Vinca alkaloid derivatives

Info

Publication number
HK20180A
HK20180A HK201/80A HK20180A HK20180A HK 20180 A HK20180 A HK 20180A HK 201/80 A HK201/80 A HK 201/80A HK 20180 A HK20180 A HK 20180A HK 20180 A HK20180 A HK 20180A
Authority
HK
Hong Kong
Prior art keywords
vinca alkaloid
alkaloid derivatives
derivatives
vinca
alkaloid
Prior art date
Application number
HK201/80A
Other languages
English (en)
Inventor
G J Cullinan
K Gerzon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK20180A publication Critical patent/HK20180A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK201/80A 1973-04-02 1980-04-17 Vinca alkaloid derivatives HK20180A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02

Publications (1)

Publication Number Publication Date
HK20180A true HK20180A (en) 1980-04-25

Family

ID=23363051

Family Applications (1)

Application Number Title Priority Date Filing Date
HK201/80A HK20180A (en) 1973-04-02 1980-04-17 Vinca alkaloid derivatives

Country Status (28)

Country Link
JP (2) JPS5919117B2 (OSRAM)
AR (2) AR204004A1 (OSRAM)
AT (1) AT340605B (OSRAM)
BE (1) BE813168A (OSRAM)
BG (3) BG21612A3 (OSRAM)
CA (1) CA1042428A (OSRAM)
CH (1) CH603669A5 (OSRAM)
CS (1) CS185223B2 (OSRAM)
CY (1) CY1044A (OSRAM)
DD (1) DD113538A5 (OSRAM)
DE (1) DE2415980A1 (OSRAM)
DK (1) DK141511B (OSRAM)
ES (2) ES424882A1 (OSRAM)
FR (1) FR2223044B1 (OSRAM)
GB (1) GB1463575A (OSRAM)
HK (1) HK20180A (OSRAM)
HU (1) HU171572B (OSRAM)
IE (1) IE39071B1 (OSRAM)
IL (1) IL44415A (OSRAM)
KE (1) KE3028A (OSRAM)
MY (1) MY8100025A (OSRAM)
NL (1) NL181079C (OSRAM)
PH (1) PH13623A (OSRAM)
RO (2) RO73524B (OSRAM)
SE (1) SE416206B (OSRAM)
SU (4) SU731900A3 (OSRAM)
YU (3) YU39719B (OSRAM)
ZA (1) ZA741674B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (OSRAM) * 1976-09-08 1982-07-07 Lilly Co Eli
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
US4210584A (en) 1979-01-15 1980-07-01 Eli Lilly And Company Vindesine synthesis
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
LU83822A1 (fr) * 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
FR2623504B1 (fr) * 1987-11-25 1990-03-09 Adir Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
AU2006207321B2 (en) 2005-01-21 2012-09-06 Astex Therapeutics Limited Pharmaceutical compounds
US7405227B2 (en) 2005-07-18 2008-07-29 Bipar Sciences, Inc. Treatment of cancer
CN101534836B (zh) 2006-09-05 2011-09-28 彼帕科学公司 Parp抑制剂在制备治疗肥胖症的药物中的用途
WO2008030883A2 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Treatment of cancer
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
EP2217227B1 (en) 2007-11-12 2013-08-21 BiPar Sciences, Inc. Treatment of breast cancer with 4-iodo-3-nitrobenzamide in combination with anti-tumor agents
JP6250710B2 (ja) * 2013-04-19 2017-12-20 曁南大学 ビンブラスチン誘導体の調製方法
CN113456797B (zh) * 2021-06-18 2024-03-08 暨南大学 长春碱类衍生物在制备治疗骨肉瘤和/或软组织肉瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Also Published As

Publication number Publication date
JPS59193895A (ja) 1984-11-02
BE813168A (fr) 1974-10-02
BG21235A3 (bg) 1976-03-20
YU39719B (en) 1985-04-30
IL44415A (en) 1978-08-31
RO73524A (ro) 1984-10-31
ES424882A1 (es) 1976-12-16
KE3028A (en) 1980-03-28
HU171572B (hu) 1978-02-28
YU113880A (en) 1982-05-31
YU39876B (en) 1985-04-30
FR2223044B1 (OSRAM) 1978-06-30
SU623522A3 (ru) 1978-09-05
NL181079C (nl) 1987-06-16
AR203882A1 (es) 1975-10-31
SU652896A3 (ru) 1979-03-15
AR204004A1 (es) 1975-11-12
RO77533A (ro) 1982-02-01
AT340605B (de) 1977-12-27
SE416206B (sv) 1980-12-08
FR2223044A1 (OSRAM) 1974-10-25
BG22831A3 (bg) 1977-04-20
CS185223B2 (en) 1978-09-15
RO73524B (ro) 1984-11-30
AU6671974A (en) 1975-09-18
IE39071B1 (en) 1978-08-02
JPS5919117B2 (ja) 1984-05-02
CY1044A (en) 1980-08-01
DD113538A5 (OSRAM) 1975-06-12
YU81774A (en) 1982-05-31
GB1463575A (en) 1977-02-02
ZA741674B (en) 1975-10-29
SU731900A3 (ru) 1980-04-30
SU784783A3 (ru) 1980-11-30
DK141511C (OSRAM) 1980-09-29
JPS6033837B2 (ja) 1985-08-05
DK141511B (da) 1980-04-08
IL44415A0 (en) 1974-06-30
DE2415980A1 (de) 1974-10-10
PH13623A (en) 1980-08-07
YU113980A (en) 1982-05-31
JPS49128000A (OSRAM) 1974-12-07
DE2415980C2 (OSRAM) 1989-11-09
ES446571A1 (es) 1977-06-16
YU39875B (en) 1985-04-30
CH603669A5 (OSRAM) 1978-08-31
CA1042428A (en) 1978-11-14
NL181079B (nl) 1987-01-16
NL7404423A (OSRAM) 1974-10-04
BG21612A3 (bg) 1976-07-20
MY8100025A (en) 1981-12-31
ATA267974A (de) 1977-04-15
IE39071L (en) 1974-10-02

Similar Documents

Publication Publication Date Title
CY1044A (en) Vinca alkaloid derivatives
HK15781A (en) Cephalosporin derivatives
ZA743760B (en) Xanthine derivatives
HK13379A (en) Pyrazino-isoquinoline derivatives
PH10309A (en) Penicillin derivatives
IL45505A0 (en) Cephalosporin derivatives
HK53980A (en) Vincamine derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
IL43704A0 (en) Lactamimide derivatives
IL45307A0 (en) Cephalosporin derivatives
PH10850A (en) Cephalosporin derivatives
PH12303A (en) Thienotriazolodiazepine derivatives
MY8100185A (en) Dihydroergopeptine derivatives
HK181A (en) Benzylpyrimidine derivatives
PH11117A (en) Cephalosporin derivatives
GB1483621A (en) Rifamycin derivatives
ZA741498B (en) Imidazo heterocyclic derivatives
IL44831A0 (en) Pyrazinoisoquinoline derivatives
ZA74675B (en) Ergoline derivatives
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
ZA747137B (en) Penicillin derivatives
IL41634A0 (en) Penicillin derivatives
IE39923B1 (en) Chlorosulphonyl-benzaldehyde derivatives